Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Joint Pain, Sicca Syndrome Increased With Aromatase Inhibitors
Link ID 1729
Title Joint Pain, Sicca Syndrome Increased With Aromatase Inhibitors
Url http://www.medscape.com/viewarticle/567696?src=rss
Description Women who take aromatase inhibitors after undergoing breast cancer surgery often have joint pain and sicca syndrome, according to a report in the November issue of The Journal of Rheumatology. Reuters Health Information
Category Articles > Rheumatology
Keywords
Date Dec 19, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Patients With Rheumatoid Arthritis Continue to Benefit After Halting TNF-alpha Inhibitor Therapy
  The improvement gained through tumor necrosis factor-alpha inhibitor therapy persists after withdrawal of treatment. Medscape Medical News
Category:   Articles > Rheumatology


2. Lung Disease in Rheumatoid Arthritis
  The authors examine the role of lung disease in rheumatoid arthritis from a clinical, epidemiologic, pathophysiologic, and therapeutic perspective.
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


3. Diffuse Large B Cell Lymphoma Most Common Subtype in Patients With Lupus
  The most common subtype of lymphoma in systemic lupus erythematosus (SLE) patients is diffuse large B cell lymphoma (DLBCL), suggest results of a study published in the December issue of the Annals of Rheumatic Diseases. Reuters Health Information
Category:   Articles > Rheumatology


4. Improving Therapeutic Options for Patients with Giant Cell Arteritis
  The optimal schedule for glucocorticoid therapy is discussed in addition to other treatments that may be used as glucocorticoid-sparing agents.
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


5. Rituximab May Be an Option for Refractory Polymyositis
  Rituximab is safe and may be effective for adult patients with active polymyositis who are refractory to corticosteroids and at least two other immunosuppressive agents, clinicians from China conclude based on results of an open-label prospective study reported in the Journal of Rheumatology for September. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS